Douglas Jermasek

Insider Reports History

Entity
Individual
Location
4300 El Camino Real, Suite 210, Los Altos, CA
Signature
/s/ Doug Jermasek
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas Jermasek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Unicycive Therapeutics, Inc. EVP of Corporate Strategy Stock Options 2.06M Aug 12, 2024 Direct
Unicycive Therapeutics, Inc. EVP of Corporate Strategy Stock Options 1.97M Apr 15, 2024 Direct

Insider Reports Filed by Douglas Jermasek

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UNCY Unicycive Therapeutics, Inc. Aug 12, 2024 1 $0 4 Aug 14, 2024 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Apr 15, 2024 1 $0 4 Apr 17, 2024 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Aug 28, 2023 1 $0 4 Aug 30, 2023 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Jul 11, 2023 5 -$50K 4 Jul 13, 2023 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Mar 8, 2023 1 $50K 4 Mar 9, 2023 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Nov 21, 2022 1 $0 4 Nov 23, 2022 EVP of Corporate Strategy
UNCY Unicycive Therapeutics, Inc. Nov 18, 2022 0 $0 3 Nov 21, 2022 EVP of Corporate Strategy